Takeda Pharmaceutical (TAK) Payables: 2018-2025

Historic Payables for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $3.1 billion.

  • Takeda Pharmaceutical's Payables fell 15.63% to $3.1 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $16.2 billion, marking a year-over-year decrease of 0.81%. This contributed to the annual value of $3.1 billion for FY2025, which is 17.77% down from last year.
  • Takeda Pharmaceutical's Payables amounted to $3.1 billion in FY2025, which was down 17.77% from $3.8 billion recorded in FY2024.
  • In the past 5 years, Takeda Pharmaceutical's Payables registered a high of $4.8 billion during FY2023, and its lowest value of $3.1 billion during FY2025.
  • For the 3-year period, Takeda Pharmaceutical's Payables averaged around $3.9 billion, with its median value being $3.8 billion (2024).
  • Per our database at Business Quant, Takeda Pharmaceutical's Payables spiked by 41.78% in 2022 and then dropped by 21.00% in 2024.
  • Yearly analysis of 5 years shows Takeda Pharmaceutical's Payables stood at $3.2 billion in 2021, then surged by 41.78% to $4.6 billion in 2022, then increased by 4.50% to $4.8 billion in 2023, then dropped by 21.00% to $3.8 billion in 2024, then fell by 17.77% to $3.1 billion in 2025.